MicroRNA‐30b regulates insulin sensitivity by targeting SERCA2b in non‐alcoholic fatty liver disease

Background & Aims Insulin resistance is strongly associated with non‐alcoholic fatty liver disease, a chronic, obesity–related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of...

Full description

Saved in:
Bibliographic Details
Published inLiver international Vol. 39; no. 8; pp. 1504 - 1513
Main Authors Dai, Li‐Li, Li, Shu‐De, Ma, Yi‐Cheng, Tang, Jun‐Rui, Lv, Jun‐Yan, Zhang, Yuan‐Qing, Miao, Ying‐Lei, Ma, Yan‐Qiong, Li, Chun‐Mei, Chu, Yi‐You, Wang, Kun‐Hua, Ma, Lan‐Qing, Zou, Cheng‐Gang
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.08.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background & Aims Insulin resistance is strongly associated with non‐alcoholic fatty liver disease, a chronic, obesity–related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of miRNAs in regulating ER stress in the liver of rats with obesity. Methods We used miRNA microarray to determine the miRNA expression profiles in the liver of rats fed with a high fat diet (HFD). We used prediction algorithms and luciferase reporter assay to identify the target gene of miRNAs. To overexpress the miRNA miR‐30b or inhibit miR‐30b rats were injected with lentivirus particles containing PGLV3‐miR‐30b or PGLV3‐miR‐30b antimiR through tail vein. Hepatic steatosis was measured using transient elastography in human subjects. Results Our data showed that miR‐30b was markedly up‐regulated in the liver of HFD–treated rats. Bioinformatic and in vitro and in vivo studies led us to identify sarco(endo)plasmic reticulum Ca2+‐ATPase 2b (SERCA2b), as a novel target of miR‐30b. Overexpression of miR‐30b induced ER stress and insulin resistance in rats fed with normal diet, whereas inhibition of miR‐30b by miR‐30b antimiR suppressed ER stress and insulin resistance in HFD–treated rats. Finally, our data demonstrated that there was a positive correlation between serum miR‐30b levels and hepatic steatosis or homoeostasis model assessment of insulin resistance (HOMA‐IR) in human subjects. Conclusions Our findings suggest that miR‐30b represents not only a potential target for the treatment of insulin resistance, but also a non‐invasive disease biomarker of NAFLD.
AbstractList Insulin resistance is strongly associated with non-alcoholic fatty liver disease, a chronic, obesity-related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of miRNAs in regulating ER stress in the liver of rats with obesity. We used miRNA microarray to determine the miRNA expression profiles in the liver of rats fed with a high fat diet (HFD). We used prediction algorithms and luciferase reporter assay to identify the target gene of miRNAs. To overexpress the miRNA miR-30b or inhibit miR-30b rats were injected with lentivirus particles containing PGLV3-miR-30b or PGLV3-miR-30b antimiR through tail vein. Hepatic steatosis was measured using transient elastography in human subjects. Our data showed that miR-30b was markedly up-regulated in the liver of HFD-treated rats. Bioinformatic and in vitro and in vivo studies led us to identify sarco(endo)plasmic reticulum Ca -ATPase 2b (SERCA2b), as a novel target of miR-30b. Overexpression of miR-30b induced ER stress and insulin resistance in rats fed with normal diet, whereas inhibition of miR-30b by miR-30b antimiR suppressed ER stress and insulin resistance in HFD-treated rats. Finally, our data demonstrated that there was a positive correlation between serum miR-30b levels and hepatic steatosis or homoeostasis model assessment of insulin resistance (HOMA-IR) in human subjects. Our findings suggest that miR-30b represents not only a potential target for the treatment of insulin resistance, but also a non-invasive disease biomarker of NAFLD.
Background & AimsInsulin resistance is strongly associated with non‐alcoholic fatty liver disease, a chronic, obesity–related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of miRNAs in regulating ER stress in the liver of rats with obesity.MethodsWe used miRNA microarray to determine the miRNA expression profiles in the liver of rats fed with a high fat diet (HFD). We used prediction algorithms and luciferase reporter assay to identify the target gene of miRNAs. To overexpress the miRNA miR‐30b or inhibit miR‐30b rats were injected with lentivirus particles containing PGLV3‐miR‐30b or PGLV3‐miR‐30b antimiR through tail vein. Hepatic steatosis was measured using transient elastography in human subjects.ResultsOur data showed that miR‐30b was markedly up‐regulated in the liver of HFD–treated rats. Bioinformatic and in vitro and in vivo studies led us to identify sarco(endo)plasmic reticulum Ca2+‐ATPase 2b (SERCA2b), as a novel target of miR‐30b. Overexpression of miR‐30b induced ER stress and insulin resistance in rats fed with normal diet, whereas inhibition of miR‐30b by miR‐30b antimiR suppressed ER stress and insulin resistance in HFD–treated rats. Finally, our data demonstrated that there was a positive correlation between serum miR‐30b levels and hepatic steatosis or homoeostasis model assessment of insulin resistance (HOMA‐IR) in human subjects.ConclusionsOur findings suggest that miR‐30b represents not only a potential target for the treatment of insulin resistance, but also a non‐invasive disease biomarker of NAFLD.
Insulin resistance is strongly associated with non-alcoholic fatty liver disease, a chronic, obesity-related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of miRNAs in regulating ER stress in the liver of rats with obesity.BACKGROUND & AIMSInsulin resistance is strongly associated with non-alcoholic fatty liver disease, a chronic, obesity-related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of miRNAs in regulating ER stress in the liver of rats with obesity.We used miRNA microarray to determine the miRNA expression profiles in the liver of rats fed with a high fat diet (HFD). We used prediction algorithms and luciferase reporter assay to identify the target gene of miRNAs. To overexpress the miRNA miR-30b or inhibit miR-30b rats were injected with lentivirus particles containing PGLV3-miR-30b or PGLV3-miR-30b antimiR through tail vein. Hepatic steatosis was measured using transient elastography in human subjects.METHODSWe used miRNA microarray to determine the miRNA expression profiles in the liver of rats fed with a high fat diet (HFD). We used prediction algorithms and luciferase reporter assay to identify the target gene of miRNAs. To overexpress the miRNA miR-30b or inhibit miR-30b rats were injected with lentivirus particles containing PGLV3-miR-30b or PGLV3-miR-30b antimiR through tail vein. Hepatic steatosis was measured using transient elastography in human subjects.Our data showed that miR-30b was markedly up-regulated in the liver of HFD-treated rats. Bioinformatic and in vitro and in vivo studies led us to identify sarco(endo)plasmic reticulum Ca2+ -ATPase 2b (SERCA2b), as a novel target of miR-30b. Overexpression of miR-30b induced ER stress and insulin resistance in rats fed with normal diet, whereas inhibition of miR-30b by miR-30b antimiR suppressed ER stress and insulin resistance in HFD-treated rats. Finally, our data demonstrated that there was a positive correlation between serum miR-30b levels and hepatic steatosis or homoeostasis model assessment of insulin resistance (HOMA-IR) in human subjects.RESULTSOur data showed that miR-30b was markedly up-regulated in the liver of HFD-treated rats. Bioinformatic and in vitro and in vivo studies led us to identify sarco(endo)plasmic reticulum Ca2+ -ATPase 2b (SERCA2b), as a novel target of miR-30b. Overexpression of miR-30b induced ER stress and insulin resistance in rats fed with normal diet, whereas inhibition of miR-30b by miR-30b antimiR suppressed ER stress and insulin resistance in HFD-treated rats. Finally, our data demonstrated that there was a positive correlation between serum miR-30b levels and hepatic steatosis or homoeostasis model assessment of insulin resistance (HOMA-IR) in human subjects.Our findings suggest that miR-30b represents not only a potential target for the treatment of insulin resistance, but also a non-invasive disease biomarker of NAFLD.CONCLUSIONSOur findings suggest that miR-30b represents not only a potential target for the treatment of insulin resistance, but also a non-invasive disease biomarker of NAFLD.
Background & Aims Insulin resistance is strongly associated with non‐alcoholic fatty liver disease, a chronic, obesity–related liver disease. Increased endoplasmic reticulum (ER) stress plays an important role in the development of insulin resistance. In this study, we investigated the roles of miRNAs in regulating ER stress in the liver of rats with obesity. Methods We used miRNA microarray to determine the miRNA expression profiles in the liver of rats fed with a high fat diet (HFD). We used prediction algorithms and luciferase reporter assay to identify the target gene of miRNAs. To overexpress the miRNA miR‐30b or inhibit miR‐30b rats were injected with lentivirus particles containing PGLV3‐miR‐30b or PGLV3‐miR‐30b antimiR through tail vein. Hepatic steatosis was measured using transient elastography in human subjects. Results Our data showed that miR‐30b was markedly up‐regulated in the liver of HFD–treated rats. Bioinformatic and in vitro and in vivo studies led us to identify sarco(endo)plasmic reticulum Ca2+‐ATPase 2b (SERCA2b), as a novel target of miR‐30b. Overexpression of miR‐30b induced ER stress and insulin resistance in rats fed with normal diet, whereas inhibition of miR‐30b by miR‐30b antimiR suppressed ER stress and insulin resistance in HFD–treated rats. Finally, our data demonstrated that there was a positive correlation between serum miR‐30b levels and hepatic steatosis or homoeostasis model assessment of insulin resistance (HOMA‐IR) in human subjects. Conclusions Our findings suggest that miR‐30b represents not only a potential target for the treatment of insulin resistance, but also a non‐invasive disease biomarker of NAFLD.
Author Li, Shu‐De
Tang, Jun‐Rui
Miao, Ying‐Lei
Lv, Jun‐Yan
Li, Chun‐Mei
Zhang, Yuan‐Qing
Chu, Yi‐You
Zou, Cheng‐Gang
Ma, Lan‐Qing
Ma, Yan‐Qiong
Ma, Yi‐Cheng
Wang, Kun‐Hua
Dai, Li‐Li
Author_xml – sequence: 1
  givenname: Li‐Li
  surname: Dai
  fullname: Dai, Li‐Li
  organization: Yunnan University
– sequence: 2
  givenname: Shu‐De
  surname: Li
  fullname: Li, Shu‐De
  organization: Kunming Medical University
– sequence: 3
  givenname: Yi‐Cheng
  surname: Ma
  fullname: Ma, Yi‐Cheng
  organization: Yunnan University
– sequence: 4
  givenname: Jun‐Rui
  surname: Tang
  fullname: Tang, Jun‐Rui
  organization: Kunming Medical University
– sequence: 5
  givenname: Jun‐Yan
  surname: Lv
  fullname: Lv, Jun‐Yan
  organization: Kunming Medical University
– sequence: 6
  givenname: Yuan‐Qing
  surname: Zhang
  fullname: Zhang, Yuan‐Qing
  organization: Kunming Medical University
– sequence: 7
  givenname: Ying‐Lei
  surname: Miao
  fullname: Miao, Ying‐Lei
  organization: Kunming Medical University
– sequence: 8
  givenname: Yan‐Qiong
  surname: Ma
  fullname: Ma, Yan‐Qiong
  organization: Kunming Medical University
– sequence: 9
  givenname: Chun‐Mei
  surname: Li
  fullname: Li, Chun‐Mei
  organization: Kunming Medical University
– sequence: 10
  givenname: Yi‐You
  surname: Chu
  fullname: Chu, Yi‐You
  organization: Kunming Medical University
– sequence: 11
  givenname: Kun‐Hua
  surname: Wang
  fullname: Wang, Kun‐Hua
  email: kunhuawang1@163.com
  organization: Kunming Medical University
– sequence: 12
  givenname: Lan‐Qing
  surname: Ma
  fullname: Ma, Lan‐Qing
  email: 531229897@qq.com
  organization: Kunming Medical University
– sequence: 13
  givenname: Cheng‐Gang
  orcidid: 0000-0001-5519-4402
  surname: Zou
  fullname: Zou, Cheng‐Gang
  email: chgzou@ynu.edu.cn
  organization: Yunnan University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30721562$$D View this record in MEDLINE/PubMed
BookMark eNp90b1uHCEQB3AU2Yo_kiIvECGlcYqzGWBhtzydnMTS2ZGcjxYBy56xONYB1tF1eYQ8Y57E2Oe4sJTQDMXvPxrNHKCdOEaH0Bsgx1DfSfC3x8CJkC_QPnDZzhhlsPP0p2wPHeR8TQh0XQMv0R4jkkIj6D66Ovc2jZcX8z-_fjNicHKrKejiMvYxT8FHnF3MvvhbXzbYbHDRaeWKjyv85fRyMaemQlznqXkd7Hg1Bm_xoEvVdSyXcO-z09m9QruDDtm9fqyH6NuH06-LT7Pl549ni_lyZlnD5EyblnOnRe-k4BQsBd6RphWtoMQKxvWgewbGGNkbrQlIDdoa4JaSphsGyw7R0bbvTRp_TC4XtfbZuhB0dOOUFYWOgyC0aSt994xej1OKdTpFqZBUSuCiqrePajJr16ub5Nc6bdTfHVbwfgvqInNObngiQNT9fVRdhHq4T7Unz6z1RRc_xpK0D_9L_PTBbf7dWi3Pvm8Td7Gdojg
CitedBy_id crossref_primary_10_1093_hmg_ddac088
crossref_primary_10_1016_j_biopha_2020_110655
crossref_primary_10_3390_ijms20122922
crossref_primary_10_1186_s12944_020_01261_3
crossref_primary_10_1096_fj_202401464R
crossref_primary_10_1055_a_1587_9211
crossref_primary_10_1016_j_lfs_2020_119011
crossref_primary_10_1080_21655979_2022_2026858
crossref_primary_10_3390_ijms24119168
crossref_primary_10_1016_j_taap_2022_116161
crossref_primary_10_1016_j_biopha_2021_112462
crossref_primary_10_1080_10408398_2023_2202762
crossref_primary_10_3390_biomedicines13020370
crossref_primary_10_3390_ijms241914482
crossref_primary_10_1016_j_biopha_2020_109930
crossref_primary_10_1007_s00580_024_03620_3
crossref_primary_10_1016_j_ejbt_2024_10_004
crossref_primary_10_1080_14728222_2022_2170780
crossref_primary_10_1016_j_scitotenv_2021_145285
crossref_primary_10_3389_fphar_2021_770652
crossref_primary_10_1016_j_biopha_2020_110127
crossref_primary_10_3390_biomedicines11061597
crossref_primary_10_1016_j_aohep_2020_04_012
crossref_primary_10_3390_ijms20215266
crossref_primary_10_1038_s41598_024_57794_5
crossref_primary_10_1186_s13098_023_01137_3
crossref_primary_10_26599_FSHW_2024_9250096
crossref_primary_10_3389_fphar_2024_1477212
crossref_primary_10_1016_j_arr_2023_102123
crossref_primary_10_1371_journal_pone_0274794
crossref_primary_10_1016_j_phymed_2021_153845
crossref_primary_10_3389_fbioe_2022_858558
crossref_primary_10_1080_1828051X_2023_2222743
crossref_primary_10_1002_hep_31994
Cites_doi 10.1126/science.1209038
10.1016/j.jhep.2016.12.016
10.3748/wjg.v20.i2.475
10.1111/j.1440-1746.2011.06864.x
10.1136/gutjnl-2014-308430
10.1210/en.2008-0794
10.1126/science.1103160
10.1074/jbc.M109.056648
10.1126/science.1158042
10.1016/j.cell.2009.01.002
10.1002/hep.27153
10.1038/sj.emboj.7600596
10.1186/1471-2164-11-249
10.1159/000366394
10.1016/j.cell.2010.02.034
10.1038/nature09968
10.1038/nature10112
10.1152/ajpgi.00426.2010
10.1016/j.mce.2015.02.018
10.1073/pnas.1012044107
10.1016/j.cell.2011.08.033
10.1126/science.1079817
10.1126/science.1128294
10.1053/j.gastro.2006.10.014
10.1074/jbc.M115.705012
10.1073/pnas.1118922109
10.5812/hepatmon.40263
10.1371/journal.pone.0047786
10.1016/j.cell.2012.02.017
10.3390/nu9040387
10.1053/j.gastro.2004.11.018
10.1002/hep.22569
10.2174/138161210791208875
10.1016/j.jhep.2012.08.008
10.1186/s12864-015-1896-3
10.1038/nrm2199
10.1016/j.dld.2010.01.016
ContentType Journal Article
Copyright 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
2019 John Wiley & Sons A/S
Copyright_xml – notice: 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
– notice: 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
– notice: 2019 John Wiley & Sons A/S
DBID AAYXX
CITATION
NPM
7QO
7T5
7U9
8FD
FR3
H94
K9.
P64
RC3
7X8
DOI 10.1111/liv.14067
DatabaseName CrossRef
PubMed
Biotechnology Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
Genetics Abstracts
Virology and AIDS Abstracts
Biotechnology Research Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList PubMed
Genetics Abstracts
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1478-3231
EndPage 1513
ExternalDocumentID 30721562
10_1111_liv_14067
LIV14067
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Ministry of Education of the People’s Republic of China
  funderid: No. 213035A
– fundername: National Natural Science Foundation of China
  funderid: No. 81560099; No.81360128
– fundername: Yunnan Provincial Science and Technology Department
  funderid: 2018FA039
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OC
29L
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
NPM
1OB
7QO
7T5
7U9
8FD
FR3
H94
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3537-ab844ea6de76421c214905868620c634afad31bbb7dbaa017a1acb14c2059ffc3
IEDL.DBID DR2
ISSN 1478-3223
1478-3231
IngestDate Fri Jul 11 09:15:18 EDT 2025
Wed Aug 13 07:41:25 EDT 2025
Mon Jul 21 06:06:43 EDT 2025
Tue Jul 01 04:10:04 EDT 2025
Thu Apr 24 23:02:38 EDT 2025
Wed Jan 22 16:39:49 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords microRNA
NAFLD
insulin resistance
endoplasmic reticulum stress
Language English
License 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3537-ab844ea6de76421c214905868620c634afad31bbb7dbaa017a1acb14c2059ffc3
Notes Funding information
This work was supported, in part, by grants from the National Natural Science Foundation of China (No. 81560099 and No.81360128), a grant from the Ministry of Education of the People's Republic of China (No. 213035A), a key project from the Department of Science and Technology of Yunnan Province (2018FA039).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-5519-4402
PMID 30721562
PQID 2267277146
PQPubID 2045125
PageCount 10
ParticipantIDs proquest_miscellaneous_2194160258
proquest_journals_2267277146
pubmed_primary_30721562
crossref_primary_10_1111_liv_14067
crossref_citationtrail_10_1111_liv_14067
wiley_primary_10_1111_liv_14067_LIV14067
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2019
PublicationDateYYYYMMDD 2019-08-01
PublicationDate_xml – month: 08
  year: 2019
  text: August 2019
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Liver international
PublicationTitleAlternate Liver Int
PublicationYear 2019
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2010; 11
2011; 334
2010; 16
2015; 16
2010; 107
2017; 66
2010; 285
2009; 150
2010; 140
2006; 313
2012; 148
2004; 306
2008; 320
2016; 16
2014; 60
2017; 9
2009; 136
2011; 474
2011; 473
2005; 24
2014; 20
2011; 147
2011; 300
2010; 42
2013; 58
2011; 108
2007; 132
2005; 128
2016; 65
2007; 8
2008; 48
2015; 418
2012; 27
2016; 291
2012; 7
2003; 300
2014; 34
e_1_2_9_30_1
e_1_2_9_31_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_14_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_19_1
e_1_2_9_18_1
e_1_2_9_20_1
e_1_2_9_22_1
e_1_2_9_21_1
e_1_2_9_24_1
e_1_2_9_23_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
e_1_2_9_5_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
e_1_2_9_9_1
e_1_2_9_26_1
e_1_2_9_25_1
e_1_2_9_28_1
e_1_2_9_27_1
e_1_2_9_29_1
References_xml – volume: 132
  start-page: 282
  issue: 1
  year: 2007
  end-page: 293
  article-title: Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis
  publication-title: Gastroenterology
– volume: 147
  start-page: 81
  issue: 1
  year: 2011
  end-page: 94
  article-title: The Lin28/let‐7 axis regulates glucose metabolism
  publication-title: Cell
– volume: 42
  start-page: 320
  issue: 5
  year: 2010
  end-page: 330
  article-title: From the metabolic syndrome to NAFLD or vice versa?
  publication-title: Dig Liver Dis
– volume: 300
  start-page: G697
  issue: 5
  year: 2011
  end-page: 702
  article-title: Obesity, diabetes mellitus, and liver fibrosis
  publication-title: Am J Physiol Gastrointest Liver Physiol
– volume: 11
  start-page: 249
  year: 2010
  article-title: Small RNA expression and strain specificity in the rat
  publication-title: BMC Genom
– volume: 58
  start-page: 119
  issue: 1
  year: 2013
  end-page: 125
  article-title: miR‐34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non‐alcoholic fatty liver disease
  publication-title: J Hepatol
– volume: 291
  start-page: 5185
  issue: 10
  year: 2016
  end-page: 5198
  article-title: Small molecular allosteric activator of the sarco/endoplasmic reticulum Ca2+‐ATPase (SERCA) attenuates diabetes and metabolic disorders
  publication-title: J Biol Chem
– volume: 9
  start-page: E387
  issue: 4
  year: 2017
  article-title: Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments
  publication-title: Nutrients
– volume: 418
  start-page: 55
  issue: Pt 1
  year: 2015
  end-page: 65
  article-title: Metabolic syndrome and nonalcoholic fatty liver disease: is insulin resistance the link?
  publication-title: Mol Cell Endocrinol
– volume: 16
  start-page: 699
  year: 2015
  article-title: Weight‐reduction through a low‐fat diet causes differential expression of circulating microRNAs in obese C57BL/6 mice
  publication-title: BMC Genom
– volume: 24
  start-page: 1243
  issue: 6
  year: 2005
  end-page: 1255
  article-title: TRB3, a novel ER stress‐inducible gene, is induced via ATF4‐CHOP pathway and is involved in cell death
  publication-title: EMBO J
– volume: 136
  start-page: 215
  issue: 2
  year: 2009
  end-page: 233
  article-title: MicroRNAs: target recognition and regulatory functions
  publication-title: Cell
– volume: 66
  start-page: 816
  issue: 4
  year: 2017
  end-page: 824
  article-title: MicroRNA‐206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis
  publication-title: J Hepatol
– volume: 148
  start-page: 852
  issue: 5
  year: 2012
  end-page: 871
  article-title: Mechanisms for insulin resistance: common threads and missing links
  publication-title: Cell
– volume: 27
  start-page: 331
  issue: 2
  year: 2012
  end-page: 340
  article-title: Transition from hepatic steatosis to steatohepatitis: unique microRNA patterns and potential downstream functions and pathways
  publication-title: J Gastroenterol Hepatol
– volume: 300
  start-page: 1574
  issue: 5625
  year: 2003
  end-page: 1577
  article-title: TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver
  publication-title: Science
– volume: 473
  start-page: 528
  issue: 7348
  year: 2011
  end-page: 531
  article-title: Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity
  publication-title: Nature
– volume: 334
  start-page: 1081
  issue: 6059
  year: 2011
  end-page: 1086
  article-title: The unfolded protein response: from stress pathway to homeostatic regulation
  publication-title: Science
– volume: 150
  start-page: 277
  issue: 1
  year: 2009
  end-page: 285
  article-title: The molecular mechanism of endoplasmic reticulum stress‐induced apoptosis in PC‐12 neuronal cells: the protective effect of insulin‐like growth factor I
  publication-title: Endocrinology
– volume: 7
  start-page: e47786
  issue: 10
  year: 2012
  article-title: miRandola: extracellular circulating microRNAs database
  publication-title: PLoS ONE
– volume: 65
  start-page: 1850
  issue: 11
  year: 2016
  end-page: 1860
  article-title: MicroRNA‐21 is a potential link between non‐alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1‐p53‐Srebp1c pathway
  publication-title: Gut
– volume: 8
  start-page: 519
  issue: 7
  year: 2007
  end-page: 529
  article-title: Signal integration in the endoplasmic reticulum unfolded protein response
  publication-title: Nat Rev Mol Cell Biol
– volume: 140
  start-page: 900
  issue: 6
  year: 2010
  end-page: 917
  article-title: Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
  publication-title: Cell
– volume: 20
  start-page: 475
  issue: 2
  year: 2014
  end-page: 485
  article-title: Limitations of liver biopsy and non‐invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
  publication-title: World J Gastroenterol
– volume: 313
  start-page: 1137
  issue: 5790
  year: 2006
  end-page: 1140
  article-title: Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes
  publication-title: Science
– volume: 128
  start-page: 343
  issue: 2
  year: 2005
  end-page: 350
  article-title: Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
  publication-title: Gastroenterology
– volume: 34
  start-page: 1983
  issue: 6
  year: 2014
  end-page: 1997
  article-title: Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease
  publication-title: Cell Physiol Biochem
– volume: 16
  start-page: 1941
  issue: 17
  year: 2010
  end-page: 1951
  article-title: Insulin resistance in nonalcoholic fatty liver disease
  publication-title: Curr Pharm Des
– volume: 48
  start-page: 1810
  issue: 6
  year: 2008
  end-page: 1820
  article-title: Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression
  publication-title: Hepatology
– volume: 108
  start-page: 21075
  issue: 52
  year: 2011
  end-page: 21080
  article-title: Control of glucose homeostasis and insulin sensitivity by the Let‐7 family of microRNAs
  publication-title: Proc Natl Acad Sci USA
– volume: 107
  start-page: 19320
  issue: 45
  year: 2010
  end-page: 19325
  article-title: Sarco(endo)plasmic reticulum Ca2+‐ATPase 2b is a major regulator of endoplasmic reticulum stress and glucose homeostasis in obesity
  publication-title: Proc Natl Acad Sci USA
– volume: 474
  start-page: 649
  issue: 7353
  year: 2011
  end-page: 653
  article-title: MicroRNAs 103 and 107 regulate insulin sensitivity
  publication-title: Nature
– volume: 320
  start-page: 1492
  issue: 5882
  year: 2008
  end-page: 1496
  article-title: Regulation of hepatic lipogenesis by the transcription factor XBP1
  publication-title: Science
– volume: 306
  start-page: 457
  issue: 5695
  year: 2004
  end-page: 461
  article-title: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes
  publication-title: Science
– volume: 60
  start-page: 554
  issue: 2
  year: 2014
  end-page: 564
  article-title: Inhibition of microRNA‐24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia
  publication-title: Hepatology
– volume: 285
  start-page: 6198
  issue: 9
  year: 2010
  end-page: 6207
  article-title: Hepatic Bax inhibitor‐1 inhibits IRE1alpha and protects from obesity‐associated insulin resistance and glucose intolerance
  publication-title: The Journal of biological chemistry
– volume: 16
  start-page: e40263
  issue: 9
  year: 2016
  article-title: Noninvasive diagnosis of hepatic steatosis using fat attenuation parameter measured by FibroTouch and a new algorithm in CHB patients
  publication-title: Hepatitis monthly
– ident: e_1_2_9_15_1
  doi: 10.1126/science.1209038
– ident: e_1_2_9_14_1
  doi: 10.1016/j.jhep.2016.12.016
– ident: e_1_2_9_37_1
  doi: 10.3748/wjg.v20.i2.475
– ident: e_1_2_9_36_1
  doi: 10.1111/j.1440-1746.2011.06864.x
– ident: e_1_2_9_13_1
  doi: 10.1136/gutjnl-2014-308430
– ident: e_1_2_9_31_1
  doi: 10.1210/en.2008-0794
– ident: e_1_2_9_24_1
  doi: 10.1126/science.1103160
– ident: e_1_2_9_18_1
  doi: 10.1074/jbc.M109.056648
– ident: e_1_2_9_32_1
  doi: 10.1126/science.1158042
– ident: e_1_2_9_8_1
  doi: 10.1016/j.cell.2009.01.002
– ident: e_1_2_9_12_1
  doi: 10.1002/hep.27153
– ident: e_1_2_9_30_1
  doi: 10.1038/sj.emboj.7600596
– ident: e_1_2_9_33_1
  doi: 10.1186/1471-2164-11-249
– ident: e_1_2_9_34_1
  doi: 10.1159/000366394
– ident: e_1_2_9_19_1
  doi: 10.1016/j.cell.2010.02.034
– ident: e_1_2_9_22_1
  doi: 10.1038/nature09968
– ident: e_1_2_9_10_1
  doi: 10.1038/nature10112
– ident: e_1_2_9_2_1
  doi: 10.1152/ajpgi.00426.2010
– ident: e_1_2_9_7_1
  doi: 10.1016/j.mce.2015.02.018
– ident: e_1_2_9_21_1
  doi: 10.1073/pnas.1012044107
– ident: e_1_2_9_25_1
  doi: 10.1016/j.cell.2011.08.033
– ident: e_1_2_9_29_1
  doi: 10.1126/science.1079817
– ident: e_1_2_9_17_1
  doi: 10.1126/science.1128294
– ident: e_1_2_9_4_1
  doi: 10.1053/j.gastro.2006.10.014
– ident: e_1_2_9_23_1
  doi: 10.1074/jbc.M115.705012
– ident: e_1_2_9_26_1
  doi: 10.1073/pnas.1118922109
– ident: e_1_2_9_28_1
  doi: 10.5812/hepatmon.40263
– ident: e_1_2_9_27_1
  doi: 10.1371/journal.pone.0047786
– ident: e_1_2_9_20_1
  doi: 10.1016/j.cell.2012.02.017
– ident: e_1_2_9_3_1
  doi: 10.3390/nu9040387
– ident: e_1_2_9_38_1
  doi: 10.1053/j.gastro.2004.11.018
– ident: e_1_2_9_9_1
  doi: 10.1002/hep.22569
– ident: e_1_2_9_5_1
  doi: 10.2174/138161210791208875
– ident: e_1_2_9_11_1
  doi: 10.1016/j.jhep.2012.08.008
– ident: e_1_2_9_35_1
  doi: 10.1186/s12864-015-1896-3
– ident: e_1_2_9_16_1
  doi: 10.1038/nrm2199
– ident: e_1_2_9_6_1
  doi: 10.1016/j.dld.2010.01.016
SSID ssj0019951
Score 2.4259655
Snippet Background & Aims Insulin resistance is strongly associated with non‐alcoholic fatty liver disease, a chronic, obesity–related liver disease. Increased...
Insulin resistance is strongly associated with non-alcoholic fatty liver disease, a chronic, obesity-related liver disease. Increased endoplasmic reticulum...
Background & AimsInsulin resistance is strongly associated with non‐alcoholic fatty liver disease, a chronic, obesity–related liver disease. Increased...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1504
SubjectTerms Adenosine triphosphatase
Algorithms
Biomarkers
Ca2+-transporting ATPase
Calcium
Calcium ions
Diet
Disease resistance
DNA microarrays
Endoplasmic reticulum
endoplasmic reticulum stress
Fatty liver
High fat diet
Human subjects
In vivo methods and tests
Insulin
Insulin resistance
Liver
Liver diseases
microRNA
MicroRNAs
miRNA
NAFLD
Obesity
Ribonucleic acid
RNA
Steatosis
Stress
Target recognition
Title MicroRNA‐30b regulates insulin sensitivity by targeting SERCA2b in non‐alcoholic fatty liver disease
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fliv.14067
https://www.ncbi.nlm.nih.gov/pubmed/30721562
https://www.proquest.com/docview/2267277146
https://www.proquest.com/docview/2194160258
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3BbtQwEB1VPSAuBVoKCwW5CCEuqZLYSRxxWlWtSsX2sFDUQ6VoxnFExZKi7i5SOfEJfGO_pGM7iShQCXGLlLHsxB7PG_vNDMDLNJEac5KRlRSzg2IxIp00ERmX_KzBgrQLcJ4c5QfH6vAkO1mBN30sTMgPMRy4Oc3w-7VTcKT5L0o-O_vGas6bLe-_jqvlANF0SB3lIo-9s6Xc9T_bwC6rkGPxDC1v2qI_AOZNvOoNzv49OO2HGngmn3eWC9ox33_L4vif33If1jogKsZh5TyAFduuw8a4ZSf8y6V4JTw11J-5r8OdSXcDvwGfJo7BNz0aX_34KWMSF6GWvZ2LjtUu5o4SH2pSCLoUgWrOBlK835vujlNiQdGet9weQ3neMyMaXLD0zHFERHdl9BCO9_c-7B5EXbWGyMhMFhGSVspiXtvCBc-alH2vONMuAiXmiVfYYC0TIipqQuSNABM0lCiTMsJrGiM3YZV7t49BZI1qyrwmyrNSWa1Rm0KVVhPquowxHcHrft4q06UydxU1ZlXv0vCAK_9DR_BiEP0a8nf8TWirn_yqU-F5xbiUsV3BlmQE28NrVj53o4KtPV-yTFIyoGXYqEfwKCyaoRfpMs8xuuTB-qm_vfvq3duP_uHJv4s-hbsM3cpARdyC1cXF0j5jeLSg514PrgHi2w1J
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3JbhNBEC2FIAEXloTFEKBBgLhMNPv0HDhYWeSQ2AeToNyGrp4eEsWMUTwGmROfwIfwK_wEX0JVzyLCInHJgZstl93tmaruV9OvXgE88b1AqhgDxwToUoJilIPSKxzULH5WqAQlFzgPR_HgIHx5GB0uwde2FqbWh-geuHFk2PWaA5wfSP8U5ZPjDxTntNo2lMpds_hICdvsxc4m3d2nvr-9tb8xcJqeAo4OoiBxFMowNCrOTcIlntqnDMGNJNdJuDS9UBUqDzxETHJUitxVeUqjF2qfcEhR6IB-9wJc5A7irNS_Oe7EqrjW2aZ3IRMOaNdtdIyYN9RN9ezu9xukPYuQ7Ra3fQ2-tRenZracrM8rXNefftGN_F-u3nW42mBt0a-D4wYsmXIFVvulqqbvFuKZsOxXe6ywApeGDclgFY6GTFIcj_rfP38JXBSn5i33ODMz0RD3xYxZ_3XbDYELUbPpCQOIV1vjjb6PZCjKaUnfV3UH4mMtClWR9YRpMKI5FbsJB-fy92_BMo1u7oCIirBI4xwxjtLQSKmkTsLUSFQyT13l9-B56yiZbtTauWnIJGuzNppwZm9gDx53pu9riZI_Ga213pY1q9QsI-hN8DWhzbIHj7qPaX3hQyNVmumcbLyUMDshY9mD27WXdqMELK5HAJoma33t78Nnezuv7Yu7_276EC4P9od79H60ew-uEFJNa-blGixXp3Nzn9BghQ9sEAp4c95--wPjiGvH
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtQwEB6VIlVc-Gn5WShgECAuqZLYSZwDh1W3q5ayK7RQ1FvwOA5ULNmqmwUtJx6B9-BVeAqehHHiRJQfiUsP3BJlEjvOjP1N_M0MwIMw4FLFyD3D0ScHxSgPZVB4qG3ys0IlKG2A82gc7x6Ip4fR4Qp8bWNhmvwQ3Q83axn1fG0N_DgvfjLy6dEHMnOabB2jct8sP5K_Nn-yN6CP-zAMhzsvt3c9V1LA0zziiadQCmFUnJvERnjqkBwEP5I2TMKn3glVqJwHiJjkqBRpqwqUxkDokGBIUWhOzz0H50Xsp7ZOxGDS5aqyoc61dycs34AWXZfGyNKGuq6eXvx-Q7SnAXK9wg0vwbd2bBpiy7utRYVb-tMvaSP_k8G7DBcd0mb9xjSuwIop12GjX6pq9n7JHrGa-1pvKqzD2shRDDbg7chSFCfj_vfPX7iP7MS8sRXOzJw52j6bW85_U3SD4ZI1XHpCAOzFzmS7HyIJsnJW0v2qqT98pFmhKpKeWhIMc3tiV-HgTF7_GqxS6-YGsKgQRRrniHGUCiOlkjoRqZGoZJ76KuzB41ZPMu1ytduSIdOs9dmow1n9AXtwvxM9bhKU_Elos1W2zM1R84yAN4HXhJbKHtzrLtPsYreMVGlmC5IJUkLshItlD643Stq1wm1qPYLP1Nla1f7efPZs71V9cPPfRe_C2vPBkE7H-7fgAsHUtKFdbsJqdbIwtwkKVninNkEGr89abX8AJuxqdg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MicroRNA%E2%80%9030b+regulates+insulin+sensitivity+by+targeting+SERCA2b+in+non%E2%80%90alcoholic+fatty+liver+disease&rft.jtitle=Liver+international&rft.au=Dai%2C+Li%E2%80%90Li&rft.au=Li%2C+Shu%E2%80%90De&rft.au=Ma%2C+Yi%E2%80%90Cheng&rft.au=Tang%2C+Jun%E2%80%90Rui&rft.date=2019-08-01&rft.issn=1478-3223&rft.eissn=1478-3231&rft.volume=39&rft.issue=8&rft.spage=1504&rft.epage=1513&rft_id=info:doi/10.1111%2Fliv.14067&rft.externalDBID=10.1111%252Fliv.14067&rft.externalDocID=LIV14067
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-3223&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-3223&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-3223&client=summon